NCT07461805 Characterization of Type 1 Diabetes Subgroup: An Artificial Intelligence Analysis of Clinical and Glucometric Features
| NCT ID | NCT07461805 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau |
| Condition | Type 1 Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2025-11-04 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2025-11-04 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to characterize different subgroups among patients with type 1 diabetes. The main research question is: Are there distinct subtypes among people with type 1 diabetes? Participants will be invited to take part in the study by allowing access to their health data. They will not be required to undergo any additional examinations, tests, visits, or interventions.
Eligibility Criteria
Inclusion Criteria: * Individuals with type 1 diabetes (T1D) aged 18 years or older. * T1D individuals expected to have regular follow-up at the Endocrinology and Nutrition Department of Hospital de la Santa Creu i Sant Pau. * Users of continuous glucose monitoring (CGM) systems for at least the last 6 months of 2024. * Willingness and ability to provide written informed consent to participate in the study (by the patient or his/her representative). Exclusion Criteria: * Presence of severe comorbidities or medical conditions that, in the investigator's judgment, could interfere with participation in the study or the interpretation of results. This circumstance is expected to be exceptional, as the study aims to be as inclusive as possible.
Contact & Investigator
Rosa M Corcoy
PRINCIPAL INVESTIGATOR
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Frequently Asked Questions
Who can join the NCT07461805 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 1 Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07461805 currently recruiting?
Yes, NCT07461805 is actively recruiting participants. Contact the research team at esafont@santpau.cat for enrollment information.
Where is the NCT07461805 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT07461805 clinical trial?
NCT07461805 is sponsored by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The principal investigator is Rosa M Corcoy at Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.